TOVX Latest Headlines

These healthcare stocks are combining strong gains with reasonable prices

at seekingalpha.com (Fri, 12-Jun 6:38 AM)

Theriva Biologics’ VCN-01 Trial Shows Prolonged Survival for Resistant Head & Neck Cancer Patients

Market Chameleon (Thu, 11-Jun 10:28 AM)

Theriva Biologics highlights promising VCN-01 Phase 1 results

at www.tipranks.com (Thu, 11-Jun 8:33 AM)

Theriva Biologics Builds Momentum with New VIRAGE Phase 2b VCN-01 Data Presentation Set for AACR 2026

Market Chameleon (Mon, 20-Apr 10:30 AM)

Theriva Biologics Receives FDA Green Light to Advance VCN-01 to Pivotal Phase 3 in Metastatic Pancreatic Cancer

Market Chameleon (Mon, 23-Mar 9:52 AM)